Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pramlintide injection drug product robustness studies.

R A Kenley1, F Bancroft, J L'Italien

  • 1Cabrillo Facility of Magellan Laboratories, Inc., 9250 Trade Place, San Diego, CA 92126, USA. rkenley@cabrillolabs.com

AAPS Pharmscitech
|January 20, 2004
PubMed
Summary

Pramlintide injection remains stable despite temperature changes and frequent dosing. This multidose parenteral formulation demonstrates robustness for patient use in chronic administration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AIR therapy: a pilot study of a clinician-assisted e-therapy for adolescents with borderline personality disorder.

Borderline personality disorder and emotion dysregulation·2025
Same author

Magma Chamber Response to Ice Unloading: Applications to Volcanism in the West Antarctic Rift System.

Geochemistry, geophysics, geosystems : G(3)·2024
Same author

Elective major general surgery in a patient who had recovered from COVID-19: considerations and complications.

Anaesthesia reports·2020
Same author

Invasive ecosystem engineers threaten benthic nitrogen cycling by altering native infaunal and biofouling communities.

Scientific reports·2020
Same author

Gastric ulceration causing thoracic spondylodiscitis: a first case of a rare complication post oesophagectomy.

BJR case reports·2019
Same author

Impact of increasing sample volume from 4 ml to 8 ml on bacterial detection rates in apheresis platelets: a meta-analysis.

Vox sanguinis·2015

Area of Science:

  • Pharmaceutical Science
  • Drug Product Stability
  • Parenteral Formulations

Background:

  • Pramlintide injection is a multidose liquid parenteral formulation used for chronic administration.
  • Understanding product robustness under patient-use conditions is crucial for multidose formulations.

Purpose of the Study:

  • To evaluate the impact of temperature excursions and dose withdrawal on pramlintide injection quality.
  • To demonstrate the robustness of pramlintide injection during simulated patient use.

Main Methods:

  • Pramlintide purity and potency were assessed using reversed-phase (RP-HPLC) and strong-cation exchange (SCX-HPLC) methods.
  • M-cresol concentration and antimicrobial preservative effectiveness were tested according to USP and European Pharmacopeia standards.

Related Experiment Videos

  • Short-term stability studies included temperature cycling (-20°C to 40°C), daily dose withdrawal (1-4 times daily), and combined stress conditions.

    • Main Results:

    • Pramlintide purity and potency remained unchanged across all tested stress conditions.
    • Product appearance, m-cresol concentration, and preservative effectiveness were not significantly affected.
    • The drug product demonstrated exceptional stability under challenging temperature and dosing scenarios.

    Conclusions:

    • Pramlintide injection exhibits remarkable robustness to temperature fluctuations and frequent dose withdrawals.
    • The multidose formulation is suitable for chronic administration, maintaining quality under conditions simulating patient use.
    • These findings support the reliability of pramlintide injection in real-world clinical settings.